Post-marketing Safety Study in Participants of All Pathologies Who Receive Gadolinium-Based Contrast Agents (GBCAs) for Contrast-Enhanced Magnetic Resonance Imaging (MR) Examination

Magnetic Resonance Imaging (MRI) Clinical Trial

Official title:
A Study of Pattern of Use for Gadolinium-Based Contrast Agents (GBCAs) in Patients Undergoing Contrast-Enhanced Magnetic Resonance (CE-MR) Examination - A Prospective, Multicenter, Observational Study

Status Completed

Clinical Trial Summary

The purpose of this study is to prospectively collect data on the pattern of use for gadolinium-based contrast agents (GBCAs) in real-life setting with special reference to Clariscan after its commercial launch in Europe and in addition quality of images, diagnostic confidence and customer satisfaction will be assessed on a Likert scale by the local radiologist/technician and spontaneously reported immediate and delayed adverse events (AEs) to assess the effectiveness and safety profile of GBCAs in clinical practice respectively.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Magnetic Resonance Imaging (MRI)

Clinical Trial Details

NCT number	NCT03455283
Study type	Observational
Source	GE Healthcare
Contact
Status	Completed
Phase
Start date	December 17, 2018
Completion date	November 11, 2019

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT04151953` - Myocardial Injury in Patients With Cardiac Implantable Electronic Devices Following Magnetic Resonance Imaging
Suspended	`NCT02728336` - MRI Assessment of Patient Suitability for Cardiac Resynchronization Therapy (CRT)	N/A
Recruiting	`NCT01799616` - Efficiency and Safety Study of Pamidronate in Inflammatory Back Pain Due to Degenerative Disk Disease	Phase 2
Completed	`NCT05304143` - Efficacy of Immersive Entertainement Glasses in Magnetic Resonance Imaging (MRI)	N/A
Completed	`NCT01755143` - Evaluation of Approved Pacing Lead (Model 5076) for Use in MRI Environment	N/A